This proposal by a group that has a long history of productive collaboration aims at providing a better understanding of cell extracellular matrix interactions at the molecular level. The program integrates the use of recombinant DNA, protein and peptide chemistry, immunochemistry and cell biology techniques for these studies. Work done within this program has identified the Arg-Gly-Asp (RGD) tripeptide as an important cell attachment signal that is responsible for the recognition of fibronectin and other adhesive proteins by cells. Tjhis led to the identification and subsequent cloning of receptors for several of the adhesion proteins. Moreover, proteoglycan core proteins and proteins carrying polylactosaminoglycan chains have been cloned and novel basement membrane components identified. The focus and the key personnel of the program will remain unchanged; the new initiatives relate to the progress of the projects and new technologies to be applied. The cell adhesion studies will focus increasingly on the family of receptors known as integrins. The important questions in this field relate to the nature of signals transmitted to cells through the ligation of these receptors, the regulation of receptor expression and the ligand specificity of the receptors. The first two questions will be approached with gene transfer studies and genomic cloning. Studies on the ligand specificity of the receptors will combine recombinant DNa approaches with a new direction in the program, analysis of the cell attachment sites of adhesion proteins by protein crystallography and peptide NMR. These studies are expected to yield new RGD adhesion peptides with improved affinities and restricted receptor specificities. Such peptides will be important, for example, for further analysis of the inhibitory activity that the RGD peptides have on tumor invasion. the proteoglycan studies will focus on two areas: the analysis of proteoglycan biosynthesis with mutated recombinant core proteins and the elucidation of proteoglycan functions by gene transfer. This latter approach has opened up an important new lead in that one of the cloned proteoglycans may turn out to be an inhibitor of cell proliferation. The basement membrane studies have led to the identification of a new basement membrane protein, merosin, which has a restricted tissue distribution. Future studies will aim at the elucidation of the functional significance of merosin.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA028896-09
Application #
3093264
Study Section
(SRC)
Project Start
1981-07-01
Project End
1994-04-30
Budget Start
1989-07-01
Budget End
1990-04-30
Support Year
9
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Sanford-Burnham Medical Research Institute
Department
Type
DUNS #
009214214
City
La Jolla
State
CA
Country
United States
Zip Code
92037
McLean, G W; Brown, K; Arbuckle, M I et al. (2001) Decreased focal adhesion kinase suppresses papilloma formation during experimental mouse skin carcinogenesis. Cancer Res 61:8385-9
Assa-Munt, N; Jia, X; Laakkonen, P et al. (2001) Solution structures and integrin binding activities of an RGD peptide with two isomers. Biochemistry 40:2373-8
Baneres, J L; Roquet, F; Martin, A et al. (2000) A minimized human integrin alpha(5)beta(1) that retains ligand recognition. J Biol Chem 275:5888-903
Ellerby, H M; Arap, W; Ellerby, L M et al. (1999) Anti-cancer activity of targeted pro-apoptotic peptides. Nat Med 5:1032-8
Wang, B; Yang, H; Liu, Y C et al. (1999) Isolation of high-affinity peptide antagonists of 14-3-3 proteins by phage display. Biochemistry 38:12499-504
Miura, R; Aspberg, A; Ethell, I M et al. (1999) The proteoglycan lectin domain binds sulfated cell surface glycolipids and promotes cell adhesion. J Biol Chem 274:11431-8
Ruoslahti, E (1999) Fibronectin and its integrin receptors in cancer. Adv Cancer Res 76:1-20
Kodandapani, R; Veerapandian, L; Ni, C Z et al. (1998) Conformational change in an anti-integrin antibody: structure of OPG2 Fab bound to a beta 3 peptide. Biochem Biophys Res Commun 251:61-6
Arap, W; Pasqualini, R; Ruoslahti, E (1998) Chemotherapy targeted to tumor vasculature. Curr Opin Oncol 10:560-5
Baneres, J L; Roquet, F; Green, M et al. (1998) The cation-binding domain from the alpha subunit of integrin alpha5 beta1 is a minimal domain for fibronectin recognition. J Biol Chem 273:24744-53

Showing the most recent 10 out of 129 publications